Industry
Medical - Devices
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
Loading...
Open
3.00
Mkt cap
15M
Volume
273K
High
3.27
P/E Ratio
-0.64
52-wk high
48.79
Low
3.00
Div yield
N/A
52-wk low
1.91
Portfolio Pulse from Benzinga Newsdesk
September 18, 2024 | 1:05 pm
Portfolio Pulse from Benzinga Newsdesk
September 18, 2024 | 11:02 am
Portfolio Pulse from Benzinga Newsdesk
September 09, 2024 | 5:18 pm
Portfolio Pulse from Benzinga Newsdesk
August 20, 2024 | 7:33 pm
Portfolio Pulse from Benzinga Newsdesk
August 20, 2024 | 9:33 am
Portfolio Pulse from Benzinga Newsdesk
August 14, 2024 | 8:15 pm
Portfolio Pulse from Benzinga Newsdesk
July 23, 2024 | 4:03 pm
Portfolio Pulse from Benzinga Newsdesk
June 27, 2024 | 11:37 am
Portfolio Pulse from Benzinga Newsdesk
June 12, 2024 | 11:38 am
Portfolio Pulse from Benzinga Newsdesk
May 14, 2024 | 9:06 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.